Total Funding
67
65
Total FundingPost-IPO Equity raised
Growth Score
-20 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
19278
CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.
Sean McCarthy: President and Chief Executive OfficerPast Role: Pappas Ventures, Transactiona Partner
Carol Talkington Verser: Sr. Director & Head, Intellectual PropertyPast Role: CytomX Therapeutics, Consultant, IP Strategy
About the Company
CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. Their mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.
Women Founded
